{
  "regulatory": {
    "agency": "FDA",
    "product": "Esbriet (pirfenidone)",
    "approval_year": 2014,
    "label_highlights": [
      "Indicated for idiopathic pulmonary fibrosis.",
      "Monitor liver function before and during therapy.",
      "Avoid strong CYP1A2 inhibitors when possible."
    ],
    "url": "https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/pirfenidone-esbriet-information"
  }
}
